These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25729046)

  • 21. A combined diagnostic approach to rheumatoid arthritis using anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Oommen S; Appalaraju B; Sivadarshini S;
    Indian J Med Microbiol; 2011; 29(2):195-6. PubMed ID: 21654124
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of anti-cyclic citrullinated peptide and rheumatoid factor in diagnosis of rheumatoid arthritis.
    Cheah TE; Sockalingam S
    Int J Rheum Dis; 2012 Feb; 15(1):e1. PubMed ID: 22324958
    [No Abstract]   [Full Text] [Related]  

  • 23. A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis.
    Xibillé-Friedmann D; Bustos Rivera-Bahena C; Rojas-Serrano J; Burgos-Vargas R; Montiel-Hernández JL
    Scand J Rheumatol; 2013; 42(2):102-7. PubMed ID: 23244209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus.
    Hoffman IE; Peene I; Cebecauer L; Isenberg D; Huizinga TW; Union A; Meheus L; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
    Ann Rheum Dis; 2005 Feb; 64(2):330-2. PubMed ID: 15647444
    [No Abstract]   [Full Text] [Related]  

  • 25. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
    Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
    Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis.
    Pasquetti P; Morozzi G; Galeazzi M
    Rheumatology (Oxford); 2009 Mar; 48(3):315-6. PubMed ID: 19109316
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage.
    Fojtíková M; Tomasová Studýnková J; Filková M; Lacinová Z; Gatterová J; Pavelka K; Vencovský J; Senolt L
    Clin Exp Rheumatol; 2010; 28(6):849-54. PubMed ID: 21122264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply: To PMID 24574210.
    de Hair MJ; van de Sande MG; Ramwadhdoebe TH; van der Leij C; Maas M; Hansson M; Klareskog L; Landewé R; Serre G; van Schaardenburg D; Gerlag DM; van Baarsen LG; Tak PP
    Arthritis Rheumatol; 2014 Jun; 66(6):1683-4. PubMed ID: 24577836
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia.
    van de Stadt LA; van der Horst AR; de Koning MH; Bos WH; Wolbink GJ; van de Stadt RJ; Pruijn GJ; Dijkmans BA; van Schaardenburg D; Hamann D
    Ann Rheum Dis; 2011 Jan; 70(1):128-33. PubMed ID: 21062853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies in normals--the value of predicting rheumatoid arthritis.
    Dörner T; Hansen A
    Arthritis Res Ther; 2004; 6(6):282-4. PubMed ID: 15535841
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.
    Turesson C; Bergström U; Jacobsson LT; Truedsson L; Berglund G; Saxne T
    Ann Rheum Dis; 2011 Mar; 70(3):520-2. PubMed ID: 21081527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunological and serological tests for diagnosis of rheumatoid arthritis--introduction].
    Tanaka M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():310-2. PubMed ID: 15799368
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diagnostic studies in new onset symmetrical polyarthritis].
    Binder A; Ellis S
    Praxis (Bern 1994); 2011 Jan; 100(1):44-6. PubMed ID: 21210360
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis.
    Mierau R; Genth E
    Clin Chem Lab Med; 2006; 44(2):138-43. PubMed ID: 16475897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.
    Barcelos F; Abreu I; Patto JV; Trindade H; Teixeira A
    Acta Reumatol Port; 2009; 34(4):608-12. PubMed ID: 20087267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.
    Turesson C; Jacobsson LT; Sturfelt G; Matteson EL; Mathsson L; Rönnelid J
    Ann Rheum Dis; 2007 Jan; 66(1):59-64. PubMed ID: 16901955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic significance of combined detection of rheumatoid factor and anticyclic citrullinated peptide antibodies in rheumatoid arthritis].
    Mu R; Sun XY; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):498-500. PubMed ID: 16224521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.
    Alunno A; Caneparo V; Bistoni O; Caterbi S; Terenzi R; Gariglio M; Bartoloni E; Manzo A; Landolfo S; Gerli R
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):440-5. PubMed ID: 26316393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.